A novel liver function evaluation system using radiopharmacokinetic modeling of technetium-99m-DTPA-galactosyl human serum albumin

Nuclear Medicine Communications

Volumn 34, Issue 9, 2013, Pages 893-899

  Du, Shunda ^a   Mao, Yilei ^a   Tong, Junxiang ^b   Li, Fang ^a   Che, Lu ^a   Li, Shaohua ^a   Yang, Huayu ^a   Ba, Jiantao ^a   Hu, Nan ^a   Xing, Haiqun ^a   Lu, Xin ^a   Sang, Xinting ^a   Zhang, Xianzhong ^c,d   Wang, Xuebin ^c   Zhong, Shouxian ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d XIAMEN UNIVERSITY   (China)

Author keywords

asialoglycoprotein; galactosyl human serum albumin; liver function; scintigraphy; two compartment model

Indexed keywords

ALBUMIN; DIETHYLENETRIAMINEPENTAACETIC ACID GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; PREALBUMIN; PROTHROMBIN; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TRANSPORT; FEMALE; HEART; HUMAN; IMAGE RECONSTRUCTION; ISOTOPE LABELING; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LUNG; MALE; MAXIMUM PLASMA CONCENTRATION; PHARMACOLOGICAL PARAMETERS; PROTHROMBIN TIME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; UPTAKE INDEX;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SERUM ALBUMIN; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 84881550024     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328362e7c7     Document Type: Article

References (20)

1. Morell AG, Irvine RA, Sternlieb I, Scheinberg IH, Ashwell G. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem 1968; 243:155-159.
2. Pricer WE Jr, Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J Biol Chem 1971; 246:4825-4833.
3. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984; 87:1217-1221.
4. Weigel PH, Oka JA. Endocytosis and degradation mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. J Biol Chem 1982; 257:1201-1207.
5. Schwartz AL, Fridovich SE, Lodish HF. Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J Biol Chem 1982; 257:4230-4237.
6. Akaki S, Mitsumori A, Kanazawa S, Togami I, Takeda Y, Joja I, Hiraki Y. Technetium-99m-DTPA-galactosyl human serum albumin liver scintigraphy evaluation of regional CT/MRI attenuation/signal intensity differences. J Nucl Med 1998; 39:529-532.
7. Miki K, Kubota K, Inoue Y, Vera DR, Makuuchi M. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med 2001; 42:733-737.
8. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology 1981; 81:527-533.
9. Virgolini I, Muller C, Klepetko W, Angelberger P, Bergmann H, O'Grady J, Sinzinger H. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand. Br J Cancer 1990; 61:937-941.
10. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m galactosyl- neoglycoalbumin: in vitro characterization of receptor-mediated binding. J Nucl Med 1984; 25:779-787.
11. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. J Nucl Med 1991; 32:1169-1176.
12. Ha-Kawa SK, Tanaka Y. A quantitative model of technetium-99m-DTPA- galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 1991; 32:2233-2240.
13. Miki K, Kubota K, Kokudo N, Inoue Y, Bandai Y, Makuuchi M. Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA- galactosyl human serum albumin. J Nucl Med 1997; 38:1798-1807.
14. 99mTc-GSA and its instant lyophilized Kit for hepatic receptor imaging. J Isotopes (Chinese) 2008; 21:88-94.
15. Zhong S. Some issues regarding the development of general surgery during the last half century. Hepatobiliary Surg Nutr 2012; 1:2-4.
16. Bengmark S. Nutrition of the critically ill-emphasis on liver and pancreas. Hepatobiliary Surg Nutr 2012; 1:25-52.
17. Mao YL, Dong YN, Zhang XZ, Yang WJ, Du SD, Tong JX, Wang XB. Application of technetium galactosyl human serum albumin diethylenetriamine pentaacetic acid injection on liver imaging in mouse models with different hepatic injuries. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007; 30:404-408.
18. Fujioka H, Kawashita Y, Kamohara Y, Yamashita A, Mizoe A, Yamaguchi J, et al. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999; 28:329-333.
19. Nanashima A, Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res 2004; 28:184-190.
20. 99mTc-GSA and its verification: new one-compartment model and regression equation. Nucl Med Commun 2001; 22:773-778.